PD-L1 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-L1 monoclonal antibody, covering 2025-02-21 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients with Advanced HER2-Negative Breast Cancer with Brain Metastasis [Phase 2]